BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31848615)

  • 1. Urinary chloride concentration and progression of chronic kidney disease: results from the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease.
    Joo YS; Kim J; Park CH; Yun HR; Park JT; Chang TI; Yoo TH; Sung SA; Lee J; Oh KH; Kim SW; Kang SW; Choi KH; Ahn C; Han SH
    Nephrol Dial Transplant; 2021 Mar; 36(4):673-680. PubMed ID: 31848615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Potassium Excretion and Progression of CKD.
    Kim HW; Park JT; Yoo TH; Lee J; Chung W; Lee KB; Chae DW; Ahn C; Kang SW; Choi KH; Han SH;
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):330-340. PubMed ID: 30765533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measured sodium excretion is associated with CKD progression: results from the KNOW-CKD study.
    Kang M; Kang E; Ryu H; Hong Y; Han SS; Park SK; Hyun YY; Sung SA; Kim SW; Yoo TH; Kim J; Ahn C; Oh KH
    Nephrol Dial Transplant; 2021 Feb; 36(3):512-519. PubMed ID: 32582942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
    Tabibzadeh N; Wagner S; Metzger M; Flamant M; Houillier P; Boffa JJ; Vrtovsnik F; Thervet E; Stengel B; Haymann JP;
    Am J Kidney Dis; 2019 May; 73(5):596-604. PubMed ID: 30777634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ;
    J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD).
    Koo H; Hwang S; Kim TH; Kang SW; Oh KH; Ahn C; Kim YH
    Medicine (Baltimore); 2018 Nov; 97(44):e12820. PubMed ID: 30383635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Azukaitis K; Ju W; Kirchner M; Nair V; Smith M; Fang Z; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Yalcinkaya F; Paripovic D; Harambat J; Cakar N; Alpay H; Lugani F; Mencarelli F; Civilibal M; Erdogan H; Gellermann J; Vidal E; Tabel Y; Gimpel C; Ertan P; Yavascan O; Melk A; Querfeld U; Wühl E; Kretzler M; Schaefer F; ;
    Kidney Int; 2019 Jul; 96(1):214-221. PubMed ID: 31005273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.
    Waikar SS; Srivastava A; Palsson R; Shafi T; Hsu CY; Sharma K; Lash JP; Chen J; He J; Lieske J; Xie D; Zhang X; Feldman HI; Curhan GC;
    JAMA Intern Med; 2019 Apr; 179(4):542-551. PubMed ID: 30830167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the transtubular potassium gradient and progression of chronic kidney disease: results from KNOW-CKD.
    Lee SY; Park JT; Joo YS; Yoo TH; Lee J; Chung W; Kim YS; Kim SW; Oh KH; Ahn C; Kang SW; Choi KH; Han SH
    J Nephrol; 2021 Dec; 34(6):2063-2072. PubMed ID: 33755931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking, Smoking Cessation, and Progression of Chronic Kidney Disease: Results From KNOW-CKD Study.
    Lee S; Kang S; Joo YS; Lee C; Nam KH; Yun HR; Park JT; Chang TI; Yoo TH; Kim SW; Oh KH; Kim YH; Park SK; Kang SW; Choi KH; Ahn C; Han SH
    Nicotine Tob Res; 2021 Jan; 23(1):92-98. PubMed ID: 32364601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR; Lobato MR; Thomé FS; Veronese FV
    Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Hsu CY; Xie D; Waikar SS; Bonventre JV; Zhang X; Sabbisetti V; Mifflin TE; Coresh J; Diamantidis CJ; He J; Lora CM; Miller ER; Nelson RG; Ojo AO; Rahman M; Schelling JR; Wilson FP; Kimmel PL; Feldman HI; Vasan RS; Liu KD; ;
    Kidney Int; 2017 Jan; 91(1):196-203. PubMed ID: 28029431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between serum chloride levels and chronic kidney disease progression: a cohort study.
    Khatri M; Zitovsky J; Lee D; Nayyar K; Fazzari M; Grant C
    BMC Nephrol; 2020 May; 21(1):165. PubMed ID: 32375681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD.
    Jung CY; Heo GY; Park JT; Joo YS; Kim HW; Lim H; Chang TI; Kang EW; Yoo TH; Kang SW; Lee J; Kim SW; Oh YK; Jung JY; Oh KH; Ahn C; Han SH
    Clin Res Cardiol; 2021 Jul; 110(7):1116-1127. PubMed ID: 34003323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, Metabolic Abnormality, and Progression of CKD.
    Yun HR; Kim H; Park JT; Chang TI; Yoo TH; Kang SW; Choi KH; Sung S; Kim SW; Lee J; Oh KH; Ahn C; Han SH;
    Am J Kidney Dis; 2018 Sep; 72(3):400-410. PubMed ID: 29728317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.
    Tynkevich E; Flamant M; Haymann JP; Metzger M; Thervet E; Boffa JJ; Vrtovsnik F; Houillier P; Froissart M; Stengel B;
    Nephrol Dial Transplant; 2015 Aug; 30(8):1386-94. PubMed ID: 25817225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease.
    He WJ; Li C; Huang Z; Geng S; Rao VS; Kelly TN; Hamm LL; Grams ME; Arking DE; Appel LJ; Rebholz CM;
    Clin J Am Soc Nephrol; 2022 Jul; 17(7):966-975. PubMed ID: 35777833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.